Det skal i den forbindelse erindres, at det som led i den undersøgelse for nytilkomne, som er omhandlet i betragtning 2, konkluderedes, at ingen af de fire kinesiske selskaber, der var omfattet af nævnte undersøgelse, kunne opnå individuel behandling.
In this respect, it has to be recalled that the newcomer review investigation referred to in recital 2 concluded that no individual treatment could be granted to any of the four Chinese companies involved in the said investigation.